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annose 6-phosphate receptors (MPRs) are trans-
ported from endosomes to the trans-Golgi via a
transport process that requires the Rab9 GTPase
 
and the cargo adaptor TIP47. We have generated green
ﬂuorescent protein variants of Rab9 and determined their
localization in cultured cells. Rab9 is localized primarily in
late endosomes and is readily distinguished from the
 
trans-Golgi marker galactosyltransferase. Coexpression
of ﬂuorescent Rab9 and Rab7 revealed that these two
 
late endosome Rabs occupy distinct domains within
late endosome membranes. Cation-independent mannose
6-phosphate receptors are enriched in the Rab9 domain
relative to the Rab7 domain. TIP47 is likely to be present in
M
 
this domain because it colocalizes with the receptors in
 
ﬁxed cells, and a TIP47 mutant disrupted endosome
morphology and sequestered MPRs intracellularly. Rab9 is
 
present on endosomes that display bidirectional microtubule-
dependent motility. Rab9-positive transport vesicles fuse
 
with the trans-Golgi network as followed by video micros-
copy of live cells. These data provide the ﬁrst indication
that Rab9-mediated endosome to trans-Golgi transport can
use a vesicle (rather than a tubular) intermediate. Our data
suggest that Rab9 remains vesicle associated until docking
with the Golgi complex and is rapidly removed concomitant
with or just after membrane fusion.
 
Introduction
 
Mannose 6-phosphate receptors (MPRs)* carry newly syn-
thesized lysosomal enzymes from the Golgi to prelysosomes
and then return to the Golgi complex to reinitiate an en-
zyme delivery cycle (Kornfeld, 1992). We study the return
step: the transport of MPRs from late endosomes to the
trans-Golgi. We have shown that this step requires the Rab9
GTPase (Lombardi et al., 1993; Riederer et al., 1994), the
cargo adaptor, TIP47 (Diaz and Pfeffer, 1998; Carroll et al.,
2001), a Rab9 effector named p40 (Diaz et al., 1997), NSF,
 
 
 
-SNAP, and a protein named mapmodulin (Itin et al.,
1997, 1999).
 
TIP47 binds with high specificity to the cytosolic domains
of the cation-dependent and cation-independent MPRs
(Diaz and Pfeffer, 1998). Indeed, TIP47 fails to bind to
other proteins that are transported from late endosomes to
the Golgi complex including furin, carboxypeptidase D,
TGN38, and the HIV Nef protein (Krise et al., 2000).
TIP47 recognizes a Phe-Trp motif in the CD-MPR (Diaz
and Pfeffer, 1998) and a proline-rich region of the CI-MPR
(Orsel et al., 2000). We have shown recently that TIP47
also binds directly to Rab9 (Carroll et al., 2001). TIP47 can
bind to Rab9 and MPRs simultaneously via physically dis-
tinct domains. Moreover, Rab9 increases the affinity of
TIP47 for MPR cytoplasmic domains (Carroll et al., 2001).
In this way, it appears that Rab9 facilitates the process of
MPR cargo collection during the process of transport vesicle
formation.
But what are the transport carriers that deliver MPRs
from late endosomes to the Golgi complex? Function block-
ing anticlathrin antibodies failed to inhibit MPR recycling
to the trans-Golgi under conditions in which they strongly
interfered with transferrin endocytosis (Draper et al., 1990).
Thus, it appears that clathrin may not play a role in MPR
recycling. TIP47 may replace clathrin in this step because it
occurs as a large oligomer in cytosol, and it may have the
capacity to bind cargo and to function as a coat protein.
We report here experiments designed to visualize MPR
trafficking in live cells. Although to date we have been
unable to generate a functional fluorescent TIP47 protein,
we succeeded in monitoring green fluorescent protein (GFP)
variants of Rab9 by video microscopy. We describe here the
morphology and motility of organelles and transport vesicles
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that carry Rab9 on their surfaces. We also describe distinct
domains occupied by two late endosomal Rab GTPases:
Rab9 and Rab7.
 
Results
 
We have shown previously that Rab9 colocalizes signifi-
cantly with the CI-MPR, primarily in late endosomes but to
a small extent in the Golgi complex and displays a punctate
perinuclear “half moon” pattern in fixed cells (Lombardi et
al., 1993). A construct comprised of yellow fluorescent pro-
tein (YFP) fused to the NH
 
2
 
 terminus of Rab9 (YFP-Rab9)
was also present mostly in late endosomes in living cells (Fig.
1). The overlap was less extensive with the cyan fluorescent
protein (CFP)-tagged CD-MPR than that seen previously
with the CI-MPR. This could be due to the possibility that
much of the CFP-CD-MPR resides in the trans-Golgi net-
work (TGN) as reported by Bonifacino and colleagues (Puer-
tollano et al., 2001), whereas Rab9 and CI-MPR are pre-
dominantly in late endosomes. It is possible that the CFP
tag at the COOH terminus of the CD-MPR alters its rate of
export from the TGN.
The YFP-Rab9 staining seemed to include structures lo-
cated further away from the nucleus than those that housed
the CD-MPR in live cells or the CI-MPR in fixed cells (Fig.
1). YFP-Rab9–labeled structures were not positive for the
trans-Golgi marker galactosyltransferase (see Fig. 8). In ad-
dition, they were essentially all positive for endocytosed dex-
tran (unpublished data), confirming that YFP-Rab9 had a
primarily endosomal localization.
Membrane association of Rab9 requires that Rab9 be pre-
nylated. Significant membrane association of the GFP-Rab9
was confirmed by analyzing cell extracts by sucrose density
gradient flotation (Fig. 2). Transfected cells were harvested,
and the extract was underlaid at the bottom of a sucrose gra-
dient. After centrifugation, the gradient fractions were ana-
Figure 1. Localization of fluorescent Rab9protein in living cells. BS-C-1 cells expressing CFP-CD-MPR and YFP-Rab9 (second, third, and 
fourth columns) were analyzed by fluorescence microscopy in comparison with untransfected fixed cells (first column). Endogenous CI-MPRs 
were detected using mouse anti–CI-MPR culture supernatant. The overlays at right show CFP-CD-MPR (green), YFP-Rab9 (red), and colocalization 
of both proteins (yellow). Bar, 10  m.
Figure 2. GFP-Rab9 distribution in BS-C-1 cell extracts subjected to sucrose density gradient flotation. Fractions were collected from the 
top (fraction 1) to the bottom (fraction 18) of the gradient. Aliquots of each fraction were analyzed by immunoblot using anti-p115 (top) or 
anti-Rab9 culture supernatant (middle and bottom). 
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lyzed by immunoblot. Golgi membranes, as monitored by
the distribution of the protein p115, were found in a band
collected in fractions 5–9 of the gradient (Fig. 2); endo-
somes cofractionate with Golgi membranes under these con-
ditions (Diaz and Pfeffer, 1998). Both the GFP-Rab9 and
endogenous Rab9 protein floated to this region of the gra-
dient. In addition, we detected nonmembrane-associated
GFP-Rab9 that trailed from the fractions containing the ini-
tial homogenate at the bottom of the gradient (fractions
9–18; Fig. 2). This experiment confirms that most of the GFP-
Rab9 becomes membrane associated and cofractionates with
endogenous Rab9 protein. Nevertheless, GFP-Rab9 was less
efficiently delivered to membranes than wild-type Rab9 pro-
tein. GFP-Rab9 bound guanine nucleotides (unpublished
data), which would be a requirement for its functionality.
The less efficient membrane association could have been due
to differences in prenylation efficiency and/or differences in
interaction with modulators and effectors that mediate
membrane association because of the presence of the GFP.
 
Rab9 and Rab7 define distinct domains
 
Zerial and coworkers have shown that early endosomal Rabs
define distinct membrane domains within a single mem-
brane-bound organelle. Thus, Rab5 and Rab4 are segregated
within early endosomes and are likely to associate with dis-
tinct effectors retained in these domains by interaction with
the respective Rab proteins (Sonnichsen et al., 2000; Zerial
and McBride, 2001). Therefore, we were interested to inves-
tigate whether two late endosomal Rabs, Rab7 and Rab9,
also displayed membrane domain segregation.
Expression of YFP-Rab9 and CFP-Rab7 in BS-C-1 cells
revealed a very similar pattern of protein localization (Fig. 3,
top), but remarkably the proteins were present in distinct re-
gions. As seen before for GFP-Rab7 (Bucci et al., 2000),
Rab7 was detected in perinuclear late endosomes. As shown
in video 1 available at http://www.jcb.org/cgi/content/full/
jcb.200109030/DC1 and Fig. 3 (bottom right), Rab7 and
Rab9 were often associated with what appeared to be a single
organelle that rotated and translated along microtubules
without displaying significant mixing of the two GTPases.
The red and green labels resembled two macaroon cookies
sandwiched together. In addition, some organelles were pos-
itive for Rab7 or Rab9 but not both GTPases. Occasionally,
a rim of overlap could be detected between the two domains.
Thus, Rab7 and Rab9 appear to define distinct endosomal
domains and are not always present on the same endosome.
Quantitation of 
 
 
 
400 Rab9- and Rab7-positive struc-
tures in five cells expressing both constructs revealed that
only 15% of the Rab9 or Rab7 labeling overlapped. In other
words, in 85% of the structures scored Rab9 and Rab7 occu-
pied distinct domains (Fig. 4).
 
CI-MPRs are concentrated in Rab9-enriched 
endosome domains
 
If Rab9 and Rab7 domains are functionally distinct, MPRs
might be enriched in membranes containing Rab9 protein.
To test this, we used a monoclonal antibody that recognizes
the lumenal domain of the CI-MPR and labeled it directly
by conjugation with Texas red. We then incubated cells with
this reagent for 3 h to label MPRs. At least in CHO cells,
CI-MPRs appear at the cell surface once every 3 h as part of
their normal intracellular cycling (Sahagian and Neufeld,
1983). Moreover, the antibody we employed remains recep-
tor bound above pH 3.0 (unpublished data), and therefore
should remain receptor bound in early and late endosomes.
Under certain conditions, polyclonal antibodies can
trigger receptor delivery to lysosomes, but a huge excess
of antibody is required: for example, addition of 10%
polyclonal anti–CI-MPR antiserum for 5 h decreased re-
ceptor levels by 30% (Pfeffer, 1987). We instead added
Figure 3. YFP-Rab9 and CFP-Rab7 localize to distinct domains on 
late endosomes. See also video 1 available at http://www.jcb.org/
cgi/content/full/jcb.200109030/DC1. YFP-Rab9 (top left) and 
CFP-Rab7 (top right) in living transfected BS-C-1 cells. Overlay of 
both images (bottom) shows CFP-Rab7 (green), YFP-Rab9 (red), and 
the colocalization of both proteins (yellow). The box in the overlay 
indicates the boundaries of the enlarged image shown in the bottom 
right panel. Bar, 10  m.
Figure 4. Quantitation of the overlap between Rab9 and Rab7. 
Cells were transfected with plasmids encoding YFP-Rab9 and 
CFP-Rab7. Labeled structures containing Rab9, Rab7, or both were 
counted at high magnification on a computer screen using 
Metamorph software. Total number of structures counted (N) is 
shown for five different cells. 
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monoclonal anti–CI-MPR IgG for 3 h at 20 
 
 
 
g/ml anti-
body, which did not seem to alter MPR trafficking (see
below).
As shown in Fig. 5 A, fluorescent anti–CI-MPR IgG was
present in punctate structures throughout the cytoplasm
that resembled early and late endosomes as expected. To de-
termine the distribution of MPR IgG within late endo-
somes, we scored all Rab9- or Rab7-positive structures and
then determined the percentage of those membrane do-
mains that also housed anti–CI-MPR IgG. Although 16%
of Rab7-positive domains also contained anti-MPR IgG
(
 
n
 
 
 
  
 
1,529), 40% of Rab9-positive domains were doubly
 
positive for anti-MPR IgG (
 
n
 
 
 
  
 
370) (Fig. 5 B). These data
show that CI-MPRs are enriched in Rab9-positive regions of
late endosomes. Because it is unlikely that every molecule of
CI-MPR will have an antibody molecule attached to it, our
values are likely to represent an underestimate of the fraction
of Rab9 domains that actually contain MPRs. In addition,
our antibody labeling protocol will include MPRs en route
to the late endosome from the cell surface. Thus, it is possi-
ble that MPRs in the Rab7 domain may be en route to the
Rab9 domain.
What molecules might enrich MPRs within the Rab9 do-
main? TIP47 is likely to link Rab9 and MPRs into a com-
mon endosomal subdomain. Unfortunately, we do not yet
have a functional GFP-TIP47 to test this directly. However,
we have generated a mutant of TIP47 that binds MPRs with
wild-type affinity but is severely diminished in its ability to
bind Rab9 (Carroll et al., 2001). Expression of this mutant
protein inhibits the transport of MPRs from endosomes to
the trans-Golgi in living cells (Carroll et al., 2001).
If TIP47 is required for Rab9 domain generation, expres-
sion of the mutant protein might generate aberrant en-
dosomal structures by forming a nonfunctional Rab9-
MPR-TIP47 assembly. To test this possibility, cells stably
expressing YFP-Rab9 were transiently transfected with two
plasmids: one encoding CFP to permit detection of trans-
fected cells and a second plasmid encoding TIP47
 
SVV-AAA
 
(Carroll et al., 2001).
As shown in Fig. 6 A, expression of TIP47
 
SVV-AAA
 
 often
yielded significantly larger and unusual looking Rab9-posi-
tive structures (bottom) than seen in cells that did not ex-
press the mutant protein (top). In addition, cells expressing
the TIP47 mutant protein endocytosed significantly less
anti-MPR IgG (Fig. 6 B, middle compared with bottom or
control panel at the top). This suggests that TIP47
 
SVV-AAA
 
has sequestered MPRs intracellularly, blocking both their re-
cycling to the TGN (Carroll et al., 2001) and their ability to
cycle via the plasma membrane. TIP47 has been shown al-
ready to colocalize with MPRs in fixed cells (Diaz and Pfef-
fer, 1998) and is present in late endosomes in mutant
TIP47-expressing cells (unpublished data). Because the
TIP47 mutant can influence the appearance of Rab9-posi-
tive compartments and sequester MPRs intracellularly, the
simplest explanation would be that TIP47 is part of the
Rab9- and MPR-enriched endosomal subdomain.
 
Rab9 vesicles en route to the trans-Golgi
 
The major goal of this project was to visualize Rab9 vesicles
en route from endosomes to the trans-Golgi, since such
transport intermediates had never before been detected. This
question was complicated by the fact that endosomes and
the Golgi are found directly adjacent to each other in the
perinuclear region of the cell. Thus, distinguishing rare
transport vesicles in this crowded region of the cytoplasm is
challenging.
We took two approaches to circumvent this problem.
First, we treated cells with nocodazole to depolymerize mi-
crotubules and disperse both endosomes and the Golgi
complex (Fig. 7 A). We have shown that endosome to
trans-Golgi transport of MPRs does not require intact
microtubules; intact microtubules enhance the initial rate
Figure 5. Distribution of the CI-MPR in Rab9 and Rab7 endosomal 
subdomains. Cells expressing either GFP-Rab9 or CFP-Rab7 were 
incubated with Texas red anti–CI-MPR for 3 h and chased for 15 
min at 37 C to label a large fraction of total cellular CI-MPRs as 
shown in A. The proportion of Rab9- or Rab7-positive structures 
that contained anti–CI-MPR IgG was quantified using Metamorph 
software on a large computer screen (B). For Rab9, 370 total structures 
were counted from 8 cells; 146 of these contained anti-MPR IgG. 
For Rab7, 1,529 vesicles were counted from 15 cells; 250 of these 
contained MPR IgG. Standard error of the mean was determined 
using the values obtained for each individual cell analyzed. 
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but not the overall extent of transport (Itin et al., 1999). In
the absence of nocodazole, vesicles moved with a velocity of
 
 
 
0.75 
 
 
 
m/s; upon microtubule depolymerization, this de-
creased to 
 
 
 
0.2 
 
 
 
m/s (Fig. 7 B). Motility was bidirectional
(video 2 available at http://www.jcb.org/cgi/content/full/
jcb.200109030/DC1). Despite the loss of most high veloc-
ity motility in nocodazole-treated cells, some residual micro-
tubules were seen as were Rab9-positive vesicles moving
along them (video 3 available at http://www.jcb.org/cgi/
content/full/jcb.200109030/DC1).
Shown in Fig. 7 A and in video 3 available at http://
www.jcb.org/cgi/content/full/jcb.200109030/DC1 is a set
of time-lapse images that reveals a vesicle moving from one
Rab9-positive compartment to another. Note that transfer is
Figure 6. A TIP47 mutant disrupts the Rab9 compartment and sequesters MPRs intracellularly. (A) Cells stably expressing YFP-Rab9 were 
transiently cotransfected with plasmids encoding CFP (to detect transfected cells, left column) and TIP47
SVV-AAA. The distribution of Rab9 (right 
column) was visualized by light microscopy. (B) BS-C-1 cells were transfected with a plasmid encoding either CFP alone (top row) or CFP and 
TIP47
SVV-AAA. Cells were then incubated with Texas red anti–CI-MPR at 37 C as in Fig. 5.
Figure 7. GFP-Rab9–bearing vesicles display microtubule-based motility. See also videos 2 and 3 available at http://www.jcb.org/cgi/
content/full/jcb.200109030/DC1. BS-C-1 cells transfected with pEGFP-Rab9 were treated with or without 4  g/ml nocodazole for 1 h at 37 C 
and analyzed by time-lapse video microscopy at 37 C. (A) GFP-Rab9 localization in BS-C-1 nocodazole-treated cells and enlarged selected 
video images from a time-lapse series. The white arrowhead points to a GFP-Rab9–bearing vesicle. (B) GFP-Rab9 vesicle velocity in 
BS-C-1–transfected cells with (  nocodazole) or without (control). Bar, 5  m. 
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accomplished by a vesicle rather than a tubule. But what are
these compartments that are mixing by vesicular transfer?
To better determine the identity of the acceptor compart-
ment, we used the trans-Golgi marker CFP–galactosyltrans-
ferase.
The CFP–galactosyltransferase construct employed con-
tains 81 NH
 
2
 
-terminal amino acids of human 
 
 
 
 1,4-galacto-
syltransferase, including the membrane-anchoring peptide
that targets the fusion protein to the trans- and medial-Golgi
(Llopis et al., 1998). Upon expression in BS-C-1 cells, this
chimeric construct is also found in the trans-Golgi network
because it could be shown to overlap with AP-1 at the TGN
(unpublished data). Using immunogold EM, Llopis et al.
(1998) reported colocalization of this fluorescent galactosyl-
transferase construct with the TGN marker, TGN38. This
is important, because it has been shown previously that
MPRs recycle to sialyltransferase-positive compartments
(TGN) but not galactosyltransferase-positive compartments
(trans-Golgi) of CHO cells (Duncan and Kornfeld, 1988).
CFP-galactosyltransferase–positive structures were distinct
from YFP-Rab9 structures upon cotransfection of BS-C-1
cells (Fig. 8 A). This confirms our earlier conclusion that
most of the Rab9 is present on late endosomes; a small
amount may be on the TGN.
Close examination of these cells by video microscopy re-
vealed vesicle transfers from Rab9-positive compartments
to the trans-Golgi (Fig. 8 B; video 4 available http://
www.jcb.org/cgi/content/full/jcb.200109030/DC1). The
time-lapse series shown in the video reveals two successive
vesicle-sized intermediates that appear to be fusing directly
with what can be defined as the Golgi by virtue of its con-
tent of a bona fide Golgi marker. Both of the vesicles follow
an identical approach pathway, which is likely provided by
an unlabeled microtubule. Thus, these images capture the
transfer of Rab9 vesicles from what is likely to represent a
late endosome to the Golgi complex in real time. In addi-
tion, the data support the proposal that Rab9 remains vesicle
associated throughout vesicle budding, docking, and less
clear but possibly also, fusion events. The loss of red color
from the Golgi just before or after fusion could be due to
GDI-mediated removal of Rab9 from that compartment or
alternatively could reflect Rab9 dilution in the target mem-
brane bilayer. Indeed, the rapid loss of Rab9 staining on the
target membrane was impressive.
 
Discussion
 
Unlike the transport of proteins from the ER to the Golgi
or from the Golgi to the plasma membrane, the transport
of MPRs from endosomes to the trans-Golgi is a relatively
low volume process. For example, the ER-to-Golgi Rab1B
GTPase is 40 times more abundant in mammalian cells
than Rab9 (Soldati et al., 1995), and that pathway may in-
volve 40 times as many transport vesicles. The low volume
of endosome to trans-Golgi transport together with the
low abundance of the requisite molecular machinery have
hindered detection of transport intermediates in previous
studies. Although MPRs have been documented as cargo of
clathrin-coated vesicles that leave the TGN en route to
prelysosomal compartments (Klumperman et al., 1993),
little is known about the pathway that carries MPRs back
to the Golgi.
Figure 8. Visualization of a Rab9-
bearing vesicle fusing with the trans-
Golgi detected by time-lapse video 
microscopy. See also video 4 available 
at http://www.jcb.org/cgi/content/full/
jcb.200109030/DC1. BS-C-1 cells trans-
fected with pECFP-galactosyltransferase 
(GalT’ase) and pEYFP-Rab9 were analyzed 
by fluorescence microscopy. (A) 
GalT’ase-CFP (left) and YFP-Rab9 
(middle) in transfected cells. Overlay 
of GalT’ase-CFP (green) and YFP-Rab9 
(red) is shown on the right. (B) Enlarged 
selected video images from a time-lapse 
series of BS-C-1 cells expressing 
GalT’ase-CFP and YFP-Rab9 proteins. 
Overlay images (top row) shows 
GalT’ase-CFP (green), YFP-Rab9 (red), 
and colocalization at docking and 
possibly fusion (yellow). Overlay images 
were obtained by overlapping GalT’ase-
CFP signal (middle row) and YFP-Rab9 
signal (bottom row). N, nucleus. 
Bars, 10  m. 
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We have shown for the first time that Rab9 is present on
vesicles that bud off of Rab9-positive structures. In addition,
small Rab9-positive vesicles can fuse with the Golgi com-
plex. We do not yet know what proteins coat these vesicles,
but a prediction of our model is that they bear TIP47 on
their surfaces. In addition, Rab9 remains vesicle associated at
least through the docking reaction and possibly until after
the fusion process is complete.
We have shown that like early endosomal Rabs Rab9 occu-
pies a discrete domain on late endosome membranes that in-
clude MPRs and is likely to also include other proteins needed
for vesicle formation, docking, and fusion. Rab7 was generally
adjacent to Rab9, although some vesicles were positive for one
of the two Rabs and not the other. Because the two domains
were so distinct, it remains possible that we are visualizing two
discrete vesicles that are tightly attached to each other. How-
ever, their remarkably close association seen by video micros-
copy appeared more consistent with the Rabs occupying dis-
tinct domains in a single membrane-bound compartment. In
either case, the Rabs define distinct membrane domains.
TIP47 is likely to enrich MPRs within the Rab9 domain. In
support of this conclusion is our finding that a mutant TIP47
that binds poorly to Rab9 alters dramatically the appearance of
Rab9-positive compartments. Our working model is that the
mutant protein coassembles with native TIP47 to form an ab-
errant structure. In other work, we have shown that a myc-
tagged TIP47 coassembles with endogenous wild-type TIP47.
Such coassembled mutant complexes may sequester MPRs
within late endosomes; indeed, cells expressing the TIP47 mu-
tant endocytosed significantly less anti–MPR-IgG than control
cells and showed altered morphology of Rab9-positive com-
partments. Altogether, these data suggest that TIP47, Rab9,
and MPRs are present altogether in an endosomal subdomain.
Do the transport vesicles we have visualized contain
MPRs? MPR transport from endosomes to the Golgi com-
plex is completely dependent on Rab9 function (Lombardi
et al., 1993; Riederer et al., 1994). In addition, we have
shown here that Rab9 domains from which the vesicles bud
are enriched in CI-MPRs. Unfortunately, we could not get
enough label onto MPRs to detect their presence in nascent
vesicles containing Rab9 protein. In addition, little of the
CFP-CD-MPR is ever seen in late endosomes at steady-
state, making it unusable as a cargo marker for the retro-
grade transport route. It seems very possible that the CFP on
the cytoplasmic domain of the CD-MPR may slow the ex-
port of this receptor from the TGN.
Although some vesicles might be formed that do not con-
tain MPRs, the simplest model is that MPRs are indeed con-
tained within the Rab9-positive vesicles. Because Rab9 en-
hances the affinity of TIP47 for MPR cytoplasmic domains, it
seems reasonable to propose that these proteins are packaged
altogether into transport carriers. In any event, we never saw
tubules emerge from the Rab9 domain nor did we detect CI-
MPRs in tubules emerging from Rab9-positive structures.
Rab7 is believed to function in the homotypic fusion of late
endosomes (Feng et al., 1995; Bucci et al., 2000). This is dis-
tinct from the function of Rab9, which is needed for MPR re-
cycling to the Golgi complex (Lombardi et al., 1993; Riederer
et al., 1994). It will be of interest to determine if organelles
positive for Rab9 or Rab7 (but not both) are capable of fusing
 
with each other. If, like Rab5 in early endosomes, Rab7 orga-
nizes the homotypic late endosome fusion machinery, it is
possible that the Rab9
 
 
 
 Rab7
 
 
 
 organelles will have lost the ca-
pacity to fuse at high efficiency with the Rab7
 
 
 
 Rab9
 
 
 
 or-
ganelles. Our experiments cannot rule out the presence of
nonfluorescent Rab7 in a Rab9-positive compartment. Yet
the observations suggest an unappreciated possibility that for-
mation of a Rab9-positive Rab7-negative organelle would
yield a terminal compartment that can no longer fuse with
other late endosomes; it would only retain the capacity to bud
off Rab9 vesicles or be a target for autophagic consumption.
Therefore, late endosomes may have a mechanism to retain
Rab7 and Rab9 in distinct domains within a single mem-
brane-bound organelle to avoid such an outcome.
We have tried to construct functional fluorescent TIP47
chimeras using GFP, YFP, and CFP attached to either the
NH
 
2
 
 or COOH terminus of the protein without success. We
made second generation constructs that contained a polygly-
cine linker between the fluorescent tag and the TIP47 protein
at either end. In all cases, the resulting fusion proteins failed to
associate with membranes unlike native TIP47. We will not
give up our attempts to generate a functional fluorescent
TIP47 protein; we hope to use it to establish whether TIP47
is indeed present on transport vesicles and unlike Rab9 falls
off of the vesicles before docking and fusion events. Our
working model is that TIP47 collects Rab9 and MPRs into
nascent transport vesicles; TIP47 release would then permit
Rab9-GTP recruitment of yet to be discovered docking fac-
tors that mediate the subsequent events. We hope that future
experiments will enable us to test this working model.
 
Materials and methods
 
Antibodies and fluorescent protein fusion constructs
 
Mouse anti–CI-MPR IgG (Lombardi et al., 1993), mouse anti-Rab9 (Soldati
et al., 1993), and mouse anti-p115 antibodies (a gift from Gerry Waters,
Princeton University, Princeton, NJ) were described previously. Fluores-
cein-conjugated goat anti–rabbit and Texas red–conjugated goat anti–
mouse IgGs were purchased from Jackson ImmunoResearch Laboratories.
YFP, GFP, and CFP indicate yellow, green, and cyan fluorescent proteins,
respectively, and refer to GFP spectral variants. The parent vectors for
pEGFP-C3 (sequence data available from GenBank/EMBL/DDBJ under ac-
cession no. U57607), pECFP-C1, pECFP-N1, and pEYFP-C1 were pur-
chased from CLONTECH Laboratories, Inc. The trans-Golgi marker,
pECFP-Golgi, encoding CFP fused to the NH
 
2
 
-terminal region of human 
 
 
 
1,4-galactosyltransferase was purchased from CLONTECH Laboratories,
Inc. Rab9 cDNA (Lombardi et al., 1993) and Rab7 cDNA (a gift from
Marino Zerial, Max Planck Institute, Dresden, Germany) were cloned at
the COOH-terminal end of the GFP and color variants. CD-MPR-CFP rep-
resents CFP fused to the COOH terminus of the mouse CD-MPR (a gift
from Bernard Hoflack, Institut Pasteur, Lille, France).
 
Cell culture, antibody uptake, and nocodazole treatment
 
African green monkey kidney epithelial (BS-C-1) cells were maintained in
minimal essential medium supplemented with 7.5% FCS, penicillin, and
streptomycin. To visualize endogenous CI-MPRs, cells were washed three
times with PBS and incubated for 3 h at 37
 
 
 
C in complete media contain-
ing 20 
 
 
 
g/ml Texas red anti–CI-MPR IgG prepared with Texas red sulfonyl
chloride according to the manufacturer (2.4 moles Texas red per mole IgG;
Molecular Probes). Cells were then chased for 15 min in complete me-
dium; in some experiments, cells were fixed for 15 min in 3% paraformal-
dehyde before light microscopy. Nocodazole treatment was for 1 h at 37
 
 
 
C
in complete medium containing 4 
 
 
 
g/ml nocodazole (Sigma-Aldrich).
 
Sucrose gradient flotation
 
BS-C-1 cells were grown on 100-mm plates and transfected with pEGFP-
Rab9. After 16–20 h, cells were washed three times with PBS and once 
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with 10 mM Hepes, pH 7.4. Cells were then swollen for 15 min at 4
 
 
 
C in
10 mM Hepes, pH 7.4, supplemented with protease inhibitors (40 
 
 
 
g/ml
aprotinin, 10 
 
 
 
g/ml leupeptin, 1 
 
 
 
M pepstatin A, and 1 
 
 
 
M phenylmethyl-
sulfonyl fluoride). Cells were then harvested by scraping with a rubber po-
liceman in 100 mM KCl, 1.5 mM magnesium acetate, 25 mM Hepes, pH
7.4, supplemented with 1 mM ATP and protease inhibitors. Cell extracts
were loaded at the bottom of a nonlinear sucrose gradient (300 
 
 
 
l, 0.5 M
sucrose, 300 
 
 
 
l 1.2 M sucrose, and 800 
 
 
 
l 2.5 M sucrose) and centrifuged
for 90 min at 54,000 rpm at 4
 
 
 
C in a TLS-55 rotor (Beckman Coulter). Frac-
tions were collected from the top, and equal aliquots were resolved by
SDS-PAGE and transferred onto nitrocellulose. Protein distributions were
determined by immunoblot using mouse anti-Rab9 culture supernatant
(undiluted) and mouse anti-p115 ascites (diluted 1:750).
 
Live cell imaging and vesicle tracking
 
Cells grown on glass coverslips were observed 16–20 h after transfection
after mounting on a temperature-controlled stage. During observation,
cells were maintained in phenol red-free DME containing 7.5% FBS buff-
ered with 20 mM Hepes, pH 7.3, and covered with silicon DC-200 fluid
(Serva). Observations were performed on a Nikon Diaphot-300 inverted
microscope equipped with a cooled CCD camera (NDE/CCD; Princeton
Instruments), and images were analyzed using Metamorph (Universal Im-
aging Corp.) software. FITC, rhodamine, and dual CFP/YFP filters were
from Chroma Technology Corp. Simultaneous detection of CFP and YFP
was performed using a dual emission filter by switching between excita-
tion wavelengths with a filter wheel controlled by the Metamorph soft-
ware. Vesicle motilities were determined at 37
 
 
 
C in cells transfected 16–
20 h using the manual tracking point application of Metamorph software
and by averaging the distance moved in 10–20 adjacent time intervals.
 
Immunofluorescence microscopy
 
Immunofluorescence was performed as described by Warren et al. (1984)
using cells grown on glass coverslips. Mouse anti–CI-MPR culture superna-
tant was used undiluted. Texas red– or fluorescein isothiocyanate-conju-
gated secondary antibodies were used at 1:1,000.
 
Online supplemental material
 
Video 1 shows YFP-Rab9 (red) and CFP-Rab7 (green) in BS-C-1 cells 18 h
after transfection. Images were acquired at room temperature to slow intra-
cellular movement. Speed is 14
 
 
 
 actual. In video 2, BS-C-1 cells 20 h after
transfection with GFP-Rab9 were observed at 37
 
 
 
C. Bidirectional motility
along microtubules can be observed (compare with cells treated with no-
codazole; video 3). Speed is 5
 
 
 
 actual. In video 3, BS-C-1 cells transfected
with GFP-Rab9 were treated for 1 h with 4 
 
 
 
g/ml nocodazole. The video
shows a Rab9-bearing vesicle budding off of an organelle and fusing with
another organelle. Speed is 10
 
 
 
 actual. In video 4, BS-C-1 cells 20 h after
transfection with YFP-Rab9 (red) and CFP-galactosyltransferase (GalT’ase)
(green) were observed at 37
 
 
 
C. The video shows YFP-Rab9–bearing vesi-
cles (arrow) fusing with a CFP-GalT’ase–positive compartment. The video
(12
 
 
 
 actual speed) contains slowed sequences (3
 
 
 
 actual). Videos 1–4 are
available at http://www.jcb.org/cgi/content/full/jcb.200109030/DC1.
 
This research was supported by a grant from the National Institutes of
Health (DK37332). P. Barbero was supported in part by the Association
pour la Recherche Contre le Cancer; L. Bittova was supported by the Clif-
ford and Evelyn Cherry Fellowship Award of the American Heart Associa-
tion Western States Affiliate. We extend special thanks to Julie Theriot’s lab
for assistance with video microscopy, Kate Carroll for help with the color
figures, and members of the Pfeffer lab for their critical comments.
 
Submitted: 10 September 2001
Revised: 2 January 2002
Accepted: 2 January 2002
 
References
 
Bucci, C., P. Thomsen, P. Nicoziani, J. McCarthy, and B. van Deurs. 2000. Rab7:
a key to lysosome biogenesis. 
 
Mol. Biol. Cell.
 
 11:467–480.
Carroll, K.S., J. Hanna, I. Simon, J. Krise, P. Barbero, and S.R. Pfeffer. 2001. Role
of the Rab9 GTPase in facilitating receptor recruitment by TIP47. 
 
Science.
 
292:1373–1377.
 
Diaz, E., and S.R. Pfeffer. 1998. TIP47: a cargo selection device for mannose
6-phosphate receptor trafficking. 
 
Cell.
 
 93:433–443.
Diaz, E., F. Schimmöller, and S.R. Pfeffer. 1997. A novel Rab9 effector required
for transport from endosomes to the TGN. 
 
J. Cell Biol.
 
 138:283–290.
Draper, R.K., Y. Goda, F.M. Brodsky, and S.R. Pfeffer. 1990. Anti-clathrin anti-
bodies inhibit endocytosis but not receptor recycling to the 
 
trans
 
 Golgi net-
work in vitro. 
 
Science.
 
 248:1539–1541.
 
Duncan, J.R., and S. Kornfeld. 1988. Intracellular movement of two mannose
6-phosphate receptors: return to the Golgi apparatus
 
.
 
 
 
J. Cell Biol.
 
 106:617–
628.
Feng, Y., B. Press, and A. Wandinger-Ness. 1995. Rab 7: an important regulator of
late endocytic membrane traffic. 
 
J. Cell Biol.
 
 131:1435–1452.
Itin, C., C. Rancaño, Y. Nakajima, and S.R. Pfeffer. 1997. A novel assay reveals a
role for alpha-SNAP in mannose 6-phosphate receptor transport from endo-
somes to the TGN. 
 
J. Biol. Chem
 
. 272:27737–37744.
Itin, C., N. Ulitzur, B. Muhlbauer, and S.R. Pfeffer. 1999. Mapmodulin, cytoplas-
mic dynein, and microtubules enhance the transport of mannose 6-phos-
phate receptors from endosomes to the trans Golgi network. 
 
Mol. Biol.
 
 
 
Cell.
 
10:2191–2197.
Klumperman, J., A. Hille, T. Veenendaal, V. Oorschot, W. Stoorvogel, K. von Fig-
ura, and H.J. Geuze. 1993. Differences in the endosomal distributions of the
two mannose 6-phosphate receptors
 
.
 
 
 
J. Cell Biol.
 
 121:997–1010.
Kornfeld, S. 1992. Structure and function of the mannose 6-phosphate/insulin like
growth factor II receptors. 
 
Annu. Rev. Biochem.
 
 61:307–330.
Krise, J.P., P.M. Sincock, J.G. Orsel, and S.R. Pfeffer. 2000. Quantitative analysis
of TIP47 (tail-interacting protein of 47kD)-receptor cytoplasmic domain in-
teractions: implications for endosome-to-trans Golgi network trafficking. 
 
J.
Biol. Chem.
 
 275:25188–25193.
Llopis, J., J.M. McCaffery, A. Miyawaki, M.G. Farquhar, and R.Y. Tsien. 1998.
Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells
with green fluorescent proteins. 
 
Proc. Natl. Acad. Sci. USA.
 
 95:6803–6808.
Lombardi, D., T. Soldati, M.A. Riederer, Y. Goda, M. Zerial, and S.R. Pfeffer.
1993. Rab9 functions in transport between late endosomes and the trans
Golgi network in vitro. 
 
EMBO J.
 
 12:677–682.
Orsel, J.G., P.M. Sincock, J.P. Krise, and S.R. Pfeffer. 2000. Recognition of the
300K mannose 6-phosphate receptor cytoplasmic domain by TIP47. 
 
Proc.
Natl. Acad. Sci. USA.
 
 97:9047–9051.
Pfeffer, S.R. 1987. The endosomal concentration of a mannose 6-phosphate recep-
tor is unchanged in the absence of ligand synthesis. 
 
J. Cell Biol.
 
 105:229–
234.
Puertollano, R., R.C. Aguilar, I. Gorshkova, R.J. Crouch, and J.S. Bonifacino.
2001. Sorting of mannose 6-phosphate receptors mediated by the GGAs.
 
Science.
 
 292:1712–1716.
Riederer, M.A., T. Soldati, A.D. Shapiro, J. Lin, and S.R. Pfeffer. 1994. Lysosome
biogenesis requires mannose 6-phosphate receptor recycling from endo-
somes to the trans-Golgi network. 
 
J. Cell Biol.
 
 125:573–582.
Sahagian, G.G., and E.F. Neufeld. 1983. Biosynthesis and turnover of the man-
nose 6-phosphate receptor in cultured Chinese hamster ovary cells. 
 
J. Biol.
Chem.
 
 258:7121–7128.
Soldati, T., M.A. Riederer, and S.R. Pfeffer. 1993. Rad GDI: a solubilizing and re-
cycling factor for Rab9 protein. 
 
Mol. Biol. Cell
 
. 4:425–434.
Soldati, T., C. Rancaño, H. Geissler, and S.R. Pfeffer. 1995. Rab7 and Rab9 are re-
cruited onto late endosomes by biochemically distinguishable processes
 
. J.
Biol. Chem.
 
 270:25541–25548.
 
Sonnichsen, B., S. De Renzis, E. Nielsen, J. Rietdorf, and M. Zerial. 2000. Distinct
membrane domains on endosomes in the recycling pathway visualized by
multicolor imaging of Rab4, Rab5, and Rab11. 
 
J. Cell Biol
 
. 149:901–914.
Warren, G., J. Davoust, and A. Cockcroft. 1984. Recycling of transferrin receptors
in A431 cells is inhibited during mitosis. 
 
EMBO J.
 
 3:2217–2225.
Zerial, M., and H. McBride. 2001. Rab proteins as membrane organizers. 
 
Nat.
Rev. Mol. Cell Biol. 
 
72:107–117.